Literature DB >> 9668353

Significance of gangliosides in neuronal differentiation of neuroblastoma cells and neurite growth in tissue culture.

H Rösner1.   

Abstract

Addition of DL-threo-1-phenyl-2-decanolylamine-3-morpholino-1-propanol HCl (PDMP; 7-24 microM) or Fumonisin B1 (FB1; 30-50 microM) to SH-SY5Ytrk-A human neuroblastoma cells results within 4 days in a 40% decrease of the ganglioside content and in a reduction of nerve-growth-factor (NGF)-induced outgrowth of neuritic processes. NGF-induced enhancement of GAP-43 expression was not affected. However, unlike controls, immunostained GAP-43 appeared concentrated in defined areas of cell perikarya and mostly absent from cell processes. Presence of 20-microM exogenous GM1 for 4 days in NGF and PDMP containing cell cultures led to an increase of cell-associated GM1(15-fold), GM2 (10-fold), GM3 (15 fold), GD1a (4-fold), GD2, GD1b, and GT1b (all 3-fold), and partially reversed the PDMP (and FB1) effects on neurite growth and GAP-43 distribution. In a newly developed neuronal tissue culture system, PDMP and FB1 led to a comparable dose-dependent inhibition of neurite outgrowth from embryonic chicken spinal cord explants, which had been embedded into a fibrin matrix. In this system, addition of GM1 led to a further inhibition of neurite growth, probably due to an interaction with growth-promoting components present in the surrounding fibrin matrix.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668353     DOI: 10.1111/j.1749-6632.1998.tb09672.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

Review 1.  Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

Authors:  Alessandro Prinetti; Simona Prioni; Elena Chiricozzi; Edward H Schuchman; Vanna Chigorno; Sandro Sonnino
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

2.  The prebiotics 3'Sialyllactose and 6'Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut-brain axis.

Authors:  Andrew J Tarr; Jeffrey D Galley; Sydney E Fisher; Maciej Chichlowski; Brian M Berg; Michael T Bailey
Journal:  Brain Behav Immun       Date:  2015-07-02       Impact factor: 7.217

Review 3.  Roles of gangliosides in mouse embryogenesis and embryonic stem cell differentiation.

Authors:  Dong Hoon Kwak; Byoung Boo Seo; Kyu Tae Chang; Young Kug Choo
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

4.  In vivo and in vitro electrophysiological monitoring of rat neocortical activity after dietary fumonisin exposure.

Authors:  Ilona Banczerowski-Pelyhe; Ildikó Világi; Laszló Détri; Judit Dóczi; Ferenc Kovács; Tibor Kukorelli
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

5.  Sphingolipid metabolism and caveolin expression in gonadotropin-releasing hormone-expressing GN11 and gonadotropin-releasing hormone-secreting GT1-7 neuronal cells.

Authors:  Simona Prioni; Nicoletta Loberto; Alessandro Prinetti; Vanna Chigorno; Francesca Guzzi; Roberto Maggi; Marco Parenti; Sandro Sonnino
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 6.  Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.

Authors:  Marco Piccinini; Federica Scandroglio; Simona Prioni; Barbara Buccinnà; Nicoletta Loberto; Massimo Aureli; Vanna Chigorno; Elisa Lupino; Giovanni DeMarco; Annarosa Lomartire; Maria Teresa Rinaudo; Sandro Sonnino; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.590

7.  Differential effects of three inhibitors of glycosphingolipid biosynthesis on neuronal differentiation of embryonal carcinoma stem cells.

Authors:  Sean S Liour; Robert K Yu
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

8.  Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid.

Authors:  S Hettmer; R McCarter; S Ladisch; K Kaucic
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.